A20’s linear ubiquitin–binding motif restrains pathogenic activation of Th17 cells and IL-22–driven enteritis
Journal of Clinical Investigation · 02.09.2025 · 135 (17)
DOI: 10.1172/jci187499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.09.2025. Verfasst von Christopher J Bowman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Interleukins, Th17 Cells, Enteritis, Tumor Necrosis Factor alpha-Induced Protein 3. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
A20, encoded by the TNFAIP3 gene, is a protein linked to Crohn’s disease and celiac disease in humans. We now find that mice expressing point mutations in A20’s M1-ubiquitin–binding zinc finger 7 (ZF7) motif spontaneously develop proximal enteritis that requires both luminal microbes and T cells. Cellular and transcriptomic profiling reveals expansion of Th17 cells and exuberant expression of IL-17A and IL-22 in intestinal lamina propria of A20 ZF7 mice. While deletion of IL-17A from A20 ZF7/ZF7 mice exacerbates enteritis, deletion of IL-22 abrogates intestinal epithelial cell hyperproliferation, barrier dysfunction, and alarmin expression. Colonization of adult germ-free mice with microbiota from adult WT specific pathogen–free mice drives duodenal IL-22 expression and duodenitis. A20 ZF7/ZF7 Th17 cells autonomously express more RORγt and IL-22 after differentiation in vitro. ATAC sequencing identified an enhancer region upstream of the Il22 gene, and this enhancer demonstrated increased activating histone acetylation coupled with exaggerated Il22 transcription in A20 ZF7/ZF7 T cells. Acute inhibition of RORγt normalized histone acetylation at this enhancer. Finally, CRISPR/Cas9–mediated ablation of A20 ZF7 in human T cells increases RORγt expression and IL22 transcription. These studies link A20’s M1-ubiquitin binding function with RORγt expression, expansion of Th17 cells, and epigenetic activation of IL-22–driven enteritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine.
- Department of Pathology.
- Department of Epidemiology and Biostatistics.
- Department of Microbiology and Immunology, and.
- Department of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
- Gladstone-UCSF Institute of Genomic Immunology, San Francisco, California, USA.
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIAMS NIH HHS
- NCI NIH HHS
- National Institutes of Health
- Crohn’s and Colitis Foundation
Zitieren
APA
Bowman, C. J., Stibor, D. M., Sun, X., Lenci, N., Shimizu, H., Yamashita, E. F., Advincula, R., Kim, M. C., Turnbaugh, J. A., Sun, Y., Razani, B., Turnbaugh, P. J., Ye, C. J., Malynn, B. A., & Ma, A. (2025). A20’s linear ubiquitin–binding motif restrains pathogenic activation of Th17 cells and IL-22–driven enteritis. Journal of Clinical Investigation, 135(17). https://doi.org/10.1172/jci187499
Vancouver
Bowman CJ, Stibor DM, Sun X, Lenci N, Shimizu H, Yamashita EF, et al. A20’s linear ubiquitin–binding motif restrains pathogenic activation of Th17 cells and IL-22–driven enteritis. Journal of Clinical Investigation. 2025;135(17). doi:10.1172/jci187499
BibTeX
@article{Bowman2025,
author = {Bowman, Christopher J and Stibor, Dorothea M and Sun, Xiaofei and Lenci, Nika and Shimizu, Hiromichi and Yamashita, Emily F and Advincula, Rommel and Kim, Min Cheol and Turnbaugh, Jessie A and Sun, Yang and Razani, Bahram and Turnbaugh, Peter J and Ye, Chun Jimmie and Malynn, Barbara A and Ma, Averil},
title = {A20’s linear ubiquitin–binding motif restrains pathogenic activation of Th17 cells and IL-22–driven enteritis},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {17},
doi = {10.1172/jci187499}
}
EUVIMED